BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32353704)

  • 21. Autoimmune hematologic complications in malignant lymphoproliferative disorders.
    Sacks PV
    Arch Intern Med; 1974 Oct; 134(4):781-3. PubMed ID: 4606256
    [No Abstract]   [Full Text] [Related]  

  • 22. Rituximab-associated infections.
    Gea-Banacloche JC
    Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant lymphomas in patients with autoimmune diseases: a report of 6 cases and a review of the Japanese literature.
    Sugai S; Tachibana J; Sawada M; Shimizu S; Hirose Y; Takiguchi T; Konda S
    Jpn J Med; 1987 Aug; 26(3):339-47. PubMed ID: 3320428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseases.
    Cervetti G; Mechelli S; Riccioni R; Galimberti S; Caracciolo F; Petrini M
    Clin Exp Rheumatol; 2005; 23(6):877-80. PubMed ID: 16396708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome.
    Lim WK; Ursea R; Rao K; Buggage RR; Suhler EB; Dugan F; Chan CC; Straus SE; Nussenblatt RB
    Am J Ophthalmol; 2005 Mar; 139(3):562-3. PubMed ID: 15767081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-Hodgkin lymphoma and autoimmunity: does gender matter?
    Ansell P; Simpson J; Lightfoot T; Smith A; Kane E; Howell D; Newton R; McGonagle D; Jack A; Roman E
    Int J Cancer; 2011 Jul; 129(2):460-6. PubMed ID: 20853323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Hodgkin lymphomas of the central nervous system.
    Pisani F; Antimi M; Cantonetti M; Marciani MG; Masi M; Tribalto M; Papa G
    Ital J Neurol Sci; 1991 Oct; 12(5):453-9. PubMed ID: 1955302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases.
    Dührsen U; Augener W; Zwingers T; Brittinger G
    Br J Haematol; 1987 Oct; 67(2):235-9. PubMed ID: 3499930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
    Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
    Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune Cytopenias Occurring after Treatment with Chemoimmunotherapy for Non-Hodgkin Lymphomas.
    Oka S; Nohgawa M
    Acta Haematol; 2019; 141(2):79-83. PubMed ID: 30630159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin Lymphoma With Multiple Autoimmune Disorders: Case Report and Review of the Literature.
    Grover NS; Dittus CE; Ma AD; Park SI
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e365-e368. PubMed ID: 29980411
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.
    Jachiet V; Mekinian A; Carrat F; Grignano E; Retbi A; Boffa JJ; Ronco P; Rondeau E; Sellam J; Berenbaum F; Chazouillères O; Capron J; Alamowitch S; Chasset F; Frances C; Coppo P; Fain O;
    Leuk Lymphoma; 2018 Jun; 59(6):1399-1405. PubMed ID: 28972423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoimmune hemolytic anemia in malignant lymphomas].
    Khadzhiev E; Popova L; Raĭkov Kh
    Vutr Boles; 1989; 28(6):56-60. PubMed ID: 2633479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoma in Sjogren's syndrome.
    Pavlidis NA; Drosos AA; Papadimitriou C; Talal N; Moutsopoulos HM
    Med Pediatr Oncol; 1992; 20(4):279-83. PubMed ID: 1608349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
    Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
    Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity and lymphomagenesis.
    Goldin LR; Landgren O
    Int J Cancer; 2009 Apr; 124(7):1497-502. PubMed ID: 19089924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma.
    Jung CK; Park JS; Lee EJ; Kim SH; Kwon HC; Kim JS; Roh MS; Yoon SK; Kim KH; Han JY; Kim HJ
    J Korean Med Sci; 2004 Apr; 19(2):294-6. PubMed ID: 15082907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.
    Hoshida Y; Tomita Y; Zhiming D; Yamauchi A; Nakatsuka S; Kurasono Y; Arima Y; Tsudo M; Shintaku M; Aozasa K
    Int J Cancer; 2004 Jan; 108(3):443-9. PubMed ID: 14648712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus and non-Hodgkin's lymphomas.
    Pozzato G; Mazzaro C; Santini G; Burrone O
    Leuk Lymphoma; 1996 Jun; 22(1-2):53-60. PubMed ID: 8724528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.